Nektar Presents Positive Clinical Data From a Phase 1 Study of Etirinotecan …

Published January 26, 2014

Nektar Presents Positive Clinical Data from a Phase 1 Study of Etirinotecan …

Filed under: Phoenix Drug Treatment Centers

It is the first long-acting topoisomerase I-inhibitor with a non-overlapping mechanism of action with other agents used to treat breast cancer, which may mitigate potential cancer cross-resistance and reduce overlapping toxicities. … Nektar has an …
Read more on Wall Street Journal

Obamacare To Cover Breast Cancer Prevention Drugs

Filed under: Phoenix Drug Treatment Centers

The panel said it found "adequate evidence" that treatment with one of those drugs "can significantly reduce the relative risk (RR) for invasive ER-positive breast cancer in postmenopausal women who are at increased risk for breast cancer." The …
Read more on Huffington Post

Sonia protecting Rahul Gandhi, says Narendra Modi

Filed under: Phoenix Drug Treatment Centers

Another important aspect that Modi highlighted was the youth and said the nation is blessed in this respect, adding that the youth should be protected from drugs. “We should protect the youth of our nation from narcotics. We should have a zero …
Read more on Zee News